Emergent Biosolutions share price logo

Emergent Biosolutions

NASDAQ: EBS

Small Cap

$8.39

+0.38

(+4.74%)

Live

as on

Emergent Biosolutions Stock Performance

as on June 25, 2026 at 4:37 am IST

  • Day's Low

    Day's High

    $8.03
    $8.54
    downward going graph

    4.29%

    Downside

    1.79%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $5.62
    $14.06
    downward going graph

    33.08%

    Downside

    67.58%

    Upside

    downward going graph

Emergent Biosolutions share price movements today

Previous Close
$8.01
Open
$8.03
Volume
606.6K
Day's Low - High
$8.03 - $8.54
52 Week Low - High
$5.62 - $14.06

Emergent Biosolutions Historical Returns

1 Month Return
-5.21 %
3 Month Return
0 %
1 Year Return
+ 18.32 %
3 Year Return
-14.06 %
5 Year Return
-87.05 %

Emergent Biosolutions Stock Fundamentals & Key Indicators

Check Emergent Biosolutions market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$405.0M

EPS (TTM)

0.95

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.94%

PE Ratio (TTM)

0

PEG Ratio

0.3835

EBITDA

166.7M

Revenue (TTM)

676.8M

Profit Margin

-1.27%

Return On Equity TTM

-1.60%

Emergent Biosolutions vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Emergent Biosolutions with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
SELL$405.0M-87.05%NA-1.27%NA
BUY$23.1B209.72%19.8740.62%NA
HOLD$17.9B9.68%NA-2.04%3.1199999999999997%
BUY$38.7BNA17.915.11%2.1999999999999997%
BUY$31.8B-58.55%12.4428.04%2.58%

Stock Returns calculator for Emergent Biosolutions Stock including INR - Dollar returns

The Emergent Biosolutions stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Emergent Biosolutions investment value today

Current value as on today

₹1,36,505

Returns

₹36,505

(+36.51%)

Returns from Emergent Biosolutions Stock

₹23,929 (+23.93%)

Dollar Impact

₹12,576 (+12.58%)

Analyst Recommendation on Emergent Biosolutions Stock

Based on 9 analysts

SELL

11.11%

Buy

22.22%

Hold

66.67%

Sell

Based on 9 analysts, 66.67% of analysts recommend a 'SELL' rating for Emergent Biosolutions. Average target price of $12

Emergent Biosolutions Share Price Target

Get share price movements and forecasts by analysts on Emergent Biosolutions.

What analysts predicted

30.08%UPSIDE

Target Price

$12

Current Price

$8.39

Analyzed by

9 Analysts

Target

$12.00

Emergent Biosolutions target price $12, a slight upside of 30.08% compared to current price of $8.39. According to 9 analysts rating.

Indian Investors' Interest in Emergent Biosolutions Stock

Search interest for Emergent Biosolutions Stock has decreased by -36% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-36% versus previous 30 day period

Emergent Biosolutions Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
276
300
254
293
194
222
140
231
148
156
Gross Profit
169
140
-65
164
136
116
57
129
46
67
Operating Income
-43
39
-203
64
-9
48
0
76
-16
10
EBITDA
-13
63
-131
97
21
133
21
96
-12
48
Interest Expense
22
24
23
8
14
14
14
15
14
11
Depreciation
29
27
28
26
26
25
23
23
23
23
Income Before Tax
-54
12
-269
142
-27
92
-16
57
-50
13
Income Tax Expense
-5
3
13
27
3
24
-4
6
3
6
Net Income
-49
9
-283
114
-31
68
-12
51
-54
6
Net Profit Margin
-17.90%
3.00%
-111.15%
39.07%
-16.08%
30.60%
-8.52%
22.15%
-36.72%
4.36%

Emergent Biosolutions Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
488
560
782
1,106
1,577
1,773
1,117
1,049
1,043
742
Gross Profit
244
283
320
483
863
793
473
360
375
350
Operating Income
105
124
89
114
438
341
-170
-726
-108
110
EBITDA
132
174
155
258
609
504
15
-47
53
240
Interest Expense
7
6
9
38
31
34
37
87
71
59
Depreciation
-
42
62
110
114
123
143
131
108
95
Income Before Tax
99
118
81
77
411
303
-219
-731
-142
82
Income Tax Expense
36
36
18
22
106
83
-7
29
47
30
Net Income
51
82
62
54
305
219
-211
-760
-190
52
Net Profit Margin
10.60%
14.73%
8.01%
4.93%
19.39%
12.38%
-18.94%
-72.48%
-18.26%
7.08%

Emergent Biosolutions Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
9
-283
114
-31
68
-12
51
-54
6
Operating Cash Flow
-62
47
153
-79
-11
106
-2
77
-33
Investing Cash Flow
-10
-4
112
28
59
17
-3
-3
-2
Financing Cash Flow
40
-50
-180
0
0
-6
-15
-113
-11
Change in Cash
-32
-8
85
-50
47
118
-21
-40
-47

Emergent Biosolutions Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
82
62
54
305
230
-211
-760
-190
52
Operating Cash Flow
208
41
188
536
321
-34
-206
58
170
Investing Cash Flow
-249
-897
-96
-151
-225
-381
212
125
69
Financing Cash Flow
-51
788
-35
69
-141
481
-535
-190
-136
Change in Cash
-93
-66
55
453
-45
66
-530
-6
103

Global Institutional Holdings in Emergent Biosolutions

Funds
Holdings
BlackRock Inc
8.41%
State Street Corp
5.52%
Vanguard Portfolio Management, LLC
2.17%
Marshall Wace Asset Management Ltd
1.44%
Oak Hill Advisors LP
2.16%

Emergent Biosolutions News & Key Events

  • img

    Today's Timeline - 09 September

    Tue, 05:00 PM

    -

    Emergent BioSolutions announces $56 million contract modification to supply ACAM2000 vaccine to the U.S. government, boosting total projected sales.

Insights on Emergent Biosolutions

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 148.7M → 156.1M (in $), with an average increase of 4.7% per quarter

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, EBS has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -54.6M → 6.8M (in $), with an average increase of 902.9% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, SANDOZ GROUP AG SPONSORED ADS Switzerland has given 97.6% return, outperforming this stock by 79.3%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 6 months, EBS stock has moved down by -36.6%

About Emergent Biosolutions

Emergent BioSolutions Inc., a life sciences company, provides preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats in the United States, Canada, and internationally. It operates through Commercial Products, MCM Products, and All Other Revenues segments. The company offers ACAM2000, a smallpox and mpox vaccine; Anthrax Immune Globulin Intravenous (ANTHRASIL), a polyclonal antibody therapeutic for the treatment of inhalational anthrax; Botulism Antitoxin Heptavalent (BAT), an equine plasma antitoxin for the treatment of symptomatic botulism; BioThrax, an anthrax vaccine; CYFENDUS, a vaccine for post-exposure prophylaxis of disease following suspected or confirmed exposure to Bacillus anthracis; Ebanga, a monoclonal antibody for the treatment of infection caused by Orthoebolavirus zairense; Raxibacumab injection, a monoclonal antibody therapeutic for the treatment and prophylaxis of inhalational anthrax due to Bacillus anthracis; TEMBEXA, an oral antiviral for the treatment of smallpox disease caused by variola virus in adult and pediatric patients; and CNJ-016, a polyclonal antibody therapeutic to address complications from smallpox vaccination. It also provides NARCAN and KLOXXADO nasal sprays for the emergency treatment of known or suspected opioid overdose. In addition, the company offers contract development and manufacturing services comprising drug substance and product manufacturing, and packaging, as well as technology transfer, process, analytical development, and suite reservation services. Emergent BioSolutions Inc. was incorporated in 1998 and is headquartered in Gaithersburg, Maryland.
OrganisationEmergent Biosolutions
Headquarters300 Professional Drive, Gaithersburg, MD, United States, 20879
IndustryDrug Manufacturers - Specialty & Generic
CEOMr. Joseph C. Papa Jr., M.B.A., R.Ph.
E-voting on sharesClick here to vote

Key Management of Emergent Biosolutions

Name

Title

Ms. Coleen Glessner

Executive Vice President of Quality, Ethics & Compliance

Ms. Jessica Perl

Senior VP, Corporate Secretary & General Counsel

Mr. Richard S. Lindahl M.B.A.

Executive VP & CFO

Mr. Paul A. Williams

Senior Vice President of Products Business

Mr. Simon C. Lowry M.D.

Chief Medical Officer and Head of Research & Development

Ms. Michelle Pepin

Senior VP & Chief Human Resource Officer

Ms. Stephanie Duatschek

Chief Global Strategy & Franchise Development Officer

Mr. William Hartzel

Senior Vice President of Manufacturing & Bioservices

Mr. Frank Vargo

VP & Treasurer

Mr. Joseph C. Papa Jr., M.B.A., R.Ph.

CEO, President & Director

FAQs

What is Emergent Biosolutions share price today?

Emergent Biosolutions share price today is $8.39 as on . Emergent Biosolutions share today touched a day high of $8.54 and a low of $8.03.

What is the 52 week high and 52 week low for Emergent Biosolutions share?

Emergent Biosolutions share touched a 52 week high of $14.06 on and a 52 week low of $5.62 on . Emergent Biosolutions stock price today i.e. is trending at $8.39,which is 40.33% down from its 52 week high and 49.42% up from its 52 week low.

What is Emergent Biosolutions's market capitalisation today?

Emergent Biosolutions market capitalisation is $0.00T as on .

How to invest in Emergent Biosolutions Stock (EBS) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Emergent Biosolutions on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Emergent Biosolutions Shares that will get you 0.1788 shares as per Emergent Biosolutions share price of $8.39 per share as on June 24, 2026 at 11:07 pm IST.

What is the minimum amount required to buy Emergent Biosolutions Stock (EBS) from India?

Indian investors can start investing in Emergent Biosolutions (EBS) shares with as little as ₹94.665 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹946.65 in Emergent Biosolutions stock (as per the Rupee-Dollar exchange rate as on ). Based on Emergent Biosolutions share’s latest price of $8.39 as on June 24, 2026 at 11:07 pm IST, you will get 1.1919 shares of Emergent Biosolutions. Learn more about fractional shares .

What are the returns that Emergent Biosolutions has given to Indian investors in the last 5 years?

Emergent Biosolutions stock has given -87.05% share price returns and 27.62% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?